Effect of Topical Applications of Budesonide and Azelastine on Nasal Symptoms, Eosinophil Count and Mediator Release in Atopic Patients after Nasal Allergen Challenge during the Pollen Season

International Archives of Allergy and Immunology

Volumn 114, Issue 2, 1997, Pages 185-192

  Wang, Deyun ^a   Smitz, Johan ^b   De Waele, Marc ^c   Clement, Peter ^a  

^a Departments of Otorhinolaryngology   (Belgium)

^b Radioimmunology   (Belgium)

^c UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Azelastine; Budesonide; Eosinophils; Mediators; Nasal allergen challenge; Seasonal allergic rhinitis

Indexed keywords

AZELASTINE; BUDESONIDE; HISTAMINE; LEUKOTRIENE C4; POLLEN ANTIGEN; TRYPTASE;

ADULT; ALLERGIC RHINITIS; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; MALE; MEDIATOR; MEDIATOR RELEASE; NOSE AIRFLOW; NOSE AIRWAY RESISTANCE; NOSE SECRETION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SNEEZING; TOPICAL DRUG ADMINISTRATION;

EID: 0030870894     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237665     Document Type: Article

References (20)

1. Berman BA: Allergic rhinitis: Mechanisms and management. J Allergy Clin Immunol 1988:81: 980-991.
2. Small P: Allergic rhinitis: Some recent changes in treatment. Am J Rhinol 1987:1:127-133.
3. Corey JP: Advances in the pharmacotherapy of allergic rhinitis: Second-generation Hi-reccp-tor antagonists. Otolarygol Head Neck Surg 1993:109:584-592.
4. Meltzer HO: Nasal cytological changes following pharmacological intervention. Allergy 1995;50(suppl 23): 15-20.
5. Godthclp T, Holm AF, Blont II, Klcin-Jan A, Rijntjes E, Fokkens WJ: The effect of fluticasone propionate aqueous nasal spray on nasal mucosal inflammation in perennial allergic rhinitis. Allergy 1995:50(suppl 23):21-24.
6. Naclerio RYI: The effect of antihistamines on the immediate allergic response: A comparative review. Otolaryngol Head Neck Surg 1993; 108: 723-730.
7. Naclerio RM, Proud D, Kagey-Sobotka A, Freidhoff L, Norman PS, Lichtenstein LM: The effect of cetirizinc on early allergic response. Laryngoscope 1989:99:596-599.
8. Togias AG, Proud D, Kagey-Sobotka A, Freidhoff L, Lichtenstein LM, Naclerio RM: In vivo and in vitro effects of antihistamines on mast cell mediator release: A potentially important property in the treatment of allergic disease. Ann Allergy 1989;63:465-469.
9. Chand N: Antagonism of histamine and tcuko-trienes by azelastine in isolated guinea pig ileum. Agents Actions 1986:19:164-168.
10. De Graafint Veld T, Garrelds IM, Van Toorenenbergen AW. Mulder PGH. Ocrth van W'jik R. Bocghcim JPJ: Effect of topical levocabastinc on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis. Ann Allergy Asthma Immunol 1995:75:261-266.
11. Wang DY, Clement P, Smitz J: Effect of I, and Hantagonists on nasal symptoms and mediator release in atopic patients after nasal allergen challenge during the pollen season. Acta Otolaryngol (Stockh) 1996; 116:91-96.
12. Taborda-Barata I, Jacobson M, Walker S, Nju-ki F, Ying S, Randcv P, Durham SR, Kay AB: Effect of cetirizine and prednisolone on cellular infiltration and cytokine mRNA expression during allergen-induced late cutaneous responses. Clin Exp Allergy 1996;26:68-78.
13. Wang DY. Clement P. Smitz J. De Waele M. Derde M-P: Correlations between complaints, inflammatory cells and mediators after nasal allergen challenge and during natural allergen exposure. Int Arch Allergy Immunol 1995:106: 278-285.
14. Wang DY. Clement P. Smitz J. Derde M-P: Concentrations of chemical mediators in the nasal secretions after nasal allergen challenge in atopic patients. Eur Arch Otorhinolaryngol 1995;252(suppl): S40-S43.
15. Clement PAR, Van Dishoeck A, Van de Wal J, Stoop P, Hoek T, Van Strick R: Nasal provocation and passive anterior rhinomanometry (PAR). Clin Allergy 1981:11:293-301.
16. Biewenga J. Stoop AE. Baker HE. Swart SJ. Nauta JJP. van Kamp GJ. van der Baan S: Nasal secretions from patients with polyps and healthy individuals, collected with a new aspiration system: Evaluation of total protein and immunoglobulin concentrations. Ann Clin Bio-chcm 1991;28:260-266.
17. Gertlt Van Wijk R. Dieges PH: Comparison of nasal responsiveness to histamine, metacholine and phentolaminc in allergic rhinitis patients and controls. Clin Allergy 1987:17:563-570.
18. Knani J. Campbell A. Enander I. Peterson CGB. Michel F-B. Bousquet J: Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis. J Allergy Clin Immunol 1992:90:881-889.
19. Krause II: Antihistamines and decongestants. Otolaryngol Head Neck Surg 1992:107:835-840.
20. Wang D, Smitz J, Watcrschoot S, Clement P: An approach to the understanding of the nasal early-phase reaction induced by nasal allergen challenge. Allergy 1997:52:162-167.